Women's Health

>

Latest News

Use of Most Contraceptive Methods Declined from 2019 to 2022, Except Vasectomies, According to New Data / Image credit: ©Pixel-Shot/AdobeStock
Use of Most Contraceptive Methods Declined from 2019 to 2022, Except Vasectomies, According to New Data

May 2nd 2024

More advanced practice clinicians and fewer physicians are providing contraception services, researchers reported.

Mental Health Risks Persist for Years Following Severe Maternal Morbidity in Pregnancy / image credit depression: ©dodoardo/shutterstock.com
Mental Health Risks Persist for Years Following Severe Maternal Morbidity in Pregnancy

May 1st 2024

Final USPSTF Recommendation on  Breast Cancer Screening Lowers Starting Age from 50 to 40 Years / image credit mammography: ©okrasiuk/stock.adobe.com
Final USPSTF Recommendation on Breast Cancer Screening Lowers Starting Age from 50 to 40 Years, Highlights Racial Disparities

May 1st 2024

Poor Cardiovascular Health at Midlife Linked to Cognitive Decline in Black Women / Image credit: ©harunyigit/AdobeStock
Poor Cardiovascular Health at Midlife Linked to Cognitive Decline in Black Women

April 24th 2024

Latest CME Events & Activities

Patient, Provider and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of HR+/HER2- Breast Cancer

View More

15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

May 11, 2024

View More

Show Me Your Care Plan: Nursing Considerations for Managing Breast Cancer Patients

View More

Community Practice Connections™: The Newest Frontier in HR+ Breast Cancer—Targeting ESR1 Mutations with Next-Generation Endocrine Therapy

View More

Clinical Case Vignette Series™: 40th Annual Miami Breast Cancer Conference®

View More

Oncology Consultations®: Next Generation SERDs—Key Data and Practical Takeaways for the Community Physician

View More

Show Me the Data®: Do We Have Sea Change for Novel Approaches in HR+/HER2- Breast Cancer? CDK, PI3K/AKT, ADC, and Next-Gen SERD Strategies Assessed

View More

HER2+ Breast Cancer Tumor Board: Navigating Current and Evolving Strategies from Early Stages to Metastases

View More

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

23rd Annual International Congress on the Future of Breast Cancer® West

July 12-13, 2024

Register Now!

23rd Annual International Congress on the Future of Breast Cancer® East

July 19-20, 2024

Register Now!

Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

Show Me the Data™: Do We Have Sea Change for Novel Approaches in HR+/HER2- Breast Cancer? CDK, PI3K/AKT, ADC, and Next-Gen SERD Strategies Assessed

View More

Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease

View More

Cancer Summaries and Commentaries™: Clinical Updates from Chicago in Breast Cancer

View More

4th Annual International Congress on the Future of Women’s Health™

View More

Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Community Practice Connections™: Leveraging Multidisciplinary Teams in Early-Stage Breast Cancer When the Goal Is Cure

View More

Community Practice Connections®: Evaluating the Evolving Treatment Landscape for mHR+ Breast Cancer-How to Personalize Care and Improve Patient Outcomes

View More

Community Practice Connections™: 22nd Annual International Congress on the Future of Breast Cancer®

View More

6th Annual Precision Medicine Symposium: An Illustrated Tumor Board

October 18-19, 2024

Register Now!

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

22nd Annual School of Breast Oncology

November 7-9, 2024

Register Now!

42nd Annual CFS®: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

Medical Crossfire®: Finding The Right Place for Immunotherapy and Targeted Treatments in the Management of Endometrial Cancer

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Emerging Treatments and Evolving Paradigms in HER2-Low Breast Cancer

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

More News

© 2024 MJH Life Sciences

All rights reserved.